UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Series A Redeemable Convertible Preferred Stock	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Noncontrolling Interests in Operating Subsidiaries
Beginning balance (in shares) at Dec. 31, 2022		350,000
Beginning balance at Dec. 31, 2022		$ 19,924
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value		$ 3,230
Ending balance (in shares) at Jun. 30, 2023		350,000
Ending balance at Jun. 30, 2023		$ 23,154
Beginning balance (in shares) at Dec. 31, 2022			43,484,867
Beginning balance at Dec. 31, 2022	$ 269,322		$ 43	$ (98,258)	$ 663,284	$ (306,789)	$ 11,042
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss including noncontrolling interests in subsidiaries	(9,332)					(9,332)
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value	(3,230)				(3,230)
Dividend on Series A Redeemable Convertible Preferred Stock	(1,400)				(1,400)
Stock options exercised (in shares)			59,568
Stock options exercised	206				206
Issuance of common stock from the Rights Offering, Shares			15,068,753
Issuance of common stock from the Rights Offering	79,111		$ 15		79,096
Issuance of common stock for vesting of restricted stock units (in shares)			313,351
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)			(34,167)
Shares withheld related to net share settlement of share-based awards (in shares)			(137,577)
Shares withheld related to net share settlement of share-based awards	(595)				(595)
Compensation expense for share-based awards	1,351				1,351
Ending balance (in shares) at Jun. 30, 2023			58,754,795
Ending balance at Jun. 30, 2023	335,433		$ 58	(98,258)	738,712	(316,121)	11,042
Beginning balance (in shares) at Mar. 31, 2023		350,000
Beginning balance at Mar. 31, 2023		$ 21,478
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value		$ 1,676
Ending balance (in shares) at Jun. 30, 2023		350,000
Ending balance at Jun. 30, 2023		$ 23,154
Beginning balance (in shares) at Mar. 31, 2023			58,551,798
Beginning balance at Mar. 31, 2023	355,687		$ 58	(98,258)	740,187	(297,342)	11,042
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss including noncontrolling interests in subsidiaries	(18,779)					(18,779)
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value	(1,676)				(1,676)
Dividend on Series A Redeemable Convertible Preferred Stock	(700)				(700)
Stock options exercised (in shares)			59,568
Stock options exercised	206				206
Issuance of common stock for vesting of restricted stock units (in shares)			202,810
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)			(16,667)
Shares withheld related to net share settlement of share-based awards (in shares)			(42,714)
Shares withheld related to net share settlement of share-based awards	(179)				(179)
Compensation expense for share-based awards	874				874
Ending balance (in shares) at Jun. 30, 2023			58,754,795
Ending balance at Jun. 30, 2023	335,433		$ 58	(98,258)	738,712	(316,121)	11,042
Beginning balance (in shares) at Dec. 31, 2023		0
Beginning balance at Dec. 31, 2023		$ 0
Ending balance (in shares) at Jun. 30, 2024		0
Ending balance at Jun. 30, 2024		$ 0
Beginning balance (in shares) at Dec. 31, 2023			99,895,473
Beginning balance at Dec. 31, 2023	589,609		$ 100	(98,258)	906,153	(239,729)	21,343
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss including noncontrolling interests in subsidiaries	(9,018)					(8,632)	(386)
Contributions from noncontrolling interests in subsidiaries	15,250						15,250
Change in ownership percentage in subsidiary	0				158		(158)
Stock options exercised (in shares)			61,667
Stock options exercised	223				223
Issuance of common stock for vesting of restricted stock units (in shares)			643,182
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)			(2,802)
Shares withheld related to net share settlement of share-based awards (in shares)			(222,061)
Shares withheld related to net share settlement of share-based awards	(1,068)				(1,068)
Compensation expense for share-based awards	1,749				1,749
Ending balance (in shares) at Jun. 30, 2024			100,375,459
Ending balance at Jun. 30, 2024	596,745		$ 100	(98,258)	907,215	(248,361)	36,049
Beginning balance (in shares) at Mar. 31, 2024		0
Beginning balance at Mar. 31, 2024		$ 0
Ending balance (in shares) at Jun. 30, 2024		0
Ending balance at Jun. 30, 2024		$ 0
Beginning balance (in shares) at Mar. 31, 2024			100,021,951
Beginning balance at Mar. 31, 2024	589,604		$ 100	(98,258)	906,337	(239,915)	21,340
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss including noncontrolling interests in subsidiaries	(8,829)					(8,446)	(383)
Contributions from noncontrolling interests in subsidiaries	15,250						15,250
Change in ownership percentage in subsidiary	0				158		(158)
Stock options exercised (in shares)			61,667
Stock options exercised	223				223
Issuance of common stock for vesting of restricted stock units (in shares)			367,938
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)			(2,802)
Shares withheld related to net share settlement of share-based awards (in shares)			(73,295)
Shares withheld related to net share settlement of share-based awards	(394)				(394)
Compensation expense for share-based awards	891				891
Ending balance (in shares) at Jun. 30, 2024			100,375,459
Ending balance at Jun. 30, 2024	$ 596,745		$ 100	$ (98,258)	$ 907,215	$ (248,361)	$ 36,049